Cited by 153Genetic Neurodegenerative DiseasesAutophagy in Disease and TherapyParkinson's Disease Mechanisms and Treatments

Impaired GAPDH‐induced mitophagy contributes to the pathology of Huntington's disease

Open access
Hwang, Sunhee, Disatnik, Marie‐Hélène, Mochly‐Rosen, Daria·2015·EMBO Molecular Medicine

Abstract

Mitochondrial dysfunction is implicated in multiple neurodegenerative diseases. In order to maintain a healthy population of functional mitochondria in cells, defective mitochondria must be properly eliminated by lysosomal machinery in a process referred to as mitophagy. Here, we uncover a new molecular mechanism underlying mitophagy driven by glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH) under the pathological condition of Huntington's disease (HD) caused by expansion of polyglutamine repeats. Expression of expanded polyglutamine tracts catalytically inactivates GAPDH (iGAPDH), which triggers its selective association with damaged mitochondria in several cell culture models of HD. Through this mechanism, iGAPDH serves as a signaling molecule to induce direct engulfment of damaged mitochondria into lysosomes (micro‐mitophagy). However, abnormal interaction of mitochondrial GAPDH with long polyglutamine tracts stalled GAPDH‐mediated mitophagy, leading to accumulation of damaged mitochondria, and increased cell death. We further demonstrated that overexpression of inactive GAPDH rescues this blunted process and enhances mitochondrial function and cell survival, indicating a role for GAPDH‐driven mitophagy in the pathology of HD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/emmm.201505256

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 77

  1. Aguado C Sarkar S Korolchuk VI Criado O Vernia S Boya P Sanz P de Cordoba SR Knecht E Rubinsztein DC Laforin, the most common protein mutated in Lafora disease, regulates autophagy Hum Mol Genet 2010 19 2867 2876 20453062 PMC2893813
  2. Bahr BA Bendiske J The neuropathogenic contributions of lysosomal dysfunction J Neurochem 2002 83 481 489 12390510
  3. Bryksin AV Laktionov PP Role of glyceraldehyde-3-phosphate dehydrogenase in vesicular transport from golgi apparatus to endoplasmic reticulum Biochemistry 2008 73 619 625 18620527
  4. Burke JR Enghild JJ Martin ME Jou YS Myers RM Roses AD Vance JM Strittmatter WJ Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH Nat Med 1996 2 347 350 8612237
  5. Chang DT Rintoul GL Pandipati S Reynolds IJ Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons Neurobiol Dis 2006 22 388 400 16473015
  6. Chang YP Tsai CC Huang WC Wang CY Chen CL Lin YS Kai JI Hsieh CY Cheng YL Choi PC Autophagy facilitates IFN-gamma-induced Jak2-STAT1 activation and cellular inflammation J Biol Chem 2010 285 28715 28722 20592027 PMC2937899
  7. Colell A Ricci JE Tait S Milasta S Maurer U Bouchier-Hayes L Fitzgerald P Guio-Carrion A Waterhouse NJ Li CW GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation Cell 2007 129 983 997 17540177
  8. Colell A Green DR Ricci JE Novel roles for GAPDH in cell death and carcinogenesis Cell Death Differ 2009 16 1573 1581 19779498
  9. Cooper JK Schilling G Peters MF Herring WJ Sharp AH Kaminsky Z Masone J Khan FA Delanoy M Borchelt DR Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture Hum Mol Genet 1998 7 783 790 9536081
  10. Cortes CJ La Spada AR The many faces of autophagy dysfunction in Huntington’s disease: from mechanism to therapy Drug Discov Today 2014 19 963 971 24632005 PMC4096219
  11. Cortes CJ Miranda HC Frankowski H Batlevi Y Young JE Le A Ivanov N Sopher BL Carromeu C Muotri AR Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA Nat Neurosci 2014 17 1180 1189 25108912 PMC4180729
  12. Costa V Scorrano L Shaping the role of mitochondria in the pathogenesis of Huntington’s disease EMBO J 2012 31 1853 1864 22446390 PMC3343341
  13. Cui L Jeong H Borovecki F Parkhurst CN Tanese N Krainc D Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration Cell 2006 127 59 69 17018277
  14. Dagda RK Cherra SJ III Kulich SM Tandon A Park D Chu CT Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission J Biol Chem 2009 284 13843 13855 19279012 PMC2679485
  15. El Kadmiri N Slassi I El Moutawakil B Nadifi S Tadevosyan A Hachem A Soukri A Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer’s disease Pathol Biol 2014 62 333 336 25246025
  16. Ferrigno P Silver PA Polyglutamine expansions: proteolysis, chaperones, and the dangers of promiscuity Neuron 2000 26 9 12 10798387
  17. Glaser PE Gross RW Rapid plasmenylethanolamine-selective fusion of membrane bilayers catalyzed by an isoform of glyceraldehyde-3-phosphate dehydrogenase: discrimination between glycolytic and fusogenic roles of individual isoforms Biochemistry 1995 34 12193 12203 7547960
  18. Guo X Disatnik MH Monbureau M Shamloo M Mochly-Rosen D Qi X Inhibition of mitochondrial fragmentation diminishes Huntington’s disease-associated neurodegeneration J Clin Invest 2013 123 5371 5388 24231356 PMC3859413
  19. Hands S Sajjad MU Newton MJ Wyttenbach A In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production J Biol Chem 2011 286 44512 44520 21984825 PMC3247975
  20. Hara MR Agrawal N Kim SF Cascio MB Fujimuro M Ozeki Y Takahashi M Cheah JH Tankou SK Hester LD S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding Nat Cell Biol 2005 7 665 674 15951807
  21. Hara MR Snyder SH Nitric oxide-GAPDH-Siah: a novel cell death cascade Cell Mol Neurobiol 2006 26 527 538 16633896 PMC11520605
  22. Hwang NR Yim SH Kim YM Jeong J Song EJ Lee Y Lee JH Choi S Lee KJ Oxidative modifications of glyceraldehyde-3-phosphate dehydrogenase play a key role in its multiple cellular functions Biochem J 2009 423 253 264 19650766
  23. Igarashi S Koide R Shimohata T Yamada M Hayashi Y Takano H Date H Oyake M Sato T Sato A Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch Nat Genet 1998 18 111 117 9462738
  24. Kaushik S Cuervo AM Chaperone-mediated autophagy: a unique way to enter the lysosome world Trends Cell Biol 2012 22 407 417 22748206 PMC3408550
  25. Khalil B El Fissi N Aouane A Cabirol-Pol MJ Rival T Lievens JC PINK1-induced mitophagy promotes neuroprotection in Huntington’s disease Cell Death Dis 2015 6 e1617 25611391 PMC4669776
  26. Kim J Moody JP Edgerly CK Bordiuk OL Cormier K Smith K Beal MF Ferrante RJ Mitochondrial loss, dysfunction and altered dynamics in Huntington’s disease Hum Mol Genet 2010 19 3919 3935 20660112 PMC2947400
  27. Klockenbusch C Kast J Optimization of formaldehyde cross-linking for protein interaction analysis of non-tagged integrin beta1 J Biomed Biotechnol 2010 2010 927585 20634879 PMC2896913
  28. Kornfeld OS Hwang S Disatnik MH Chen CH Qvit N Mochly-Rosen D Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases Circ Res 2015 116 1783 1799 25999419 PMC4443500
  29. Koshy B Matilla T Burright EN Merry DE Fischbeck KH Orr HT Zoghbi HY Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase Hum Mol Genet 1996 5 1311 1318 8872471
  30. Kubli DA Gustafsson AB Mitochondria and mitophagy: the yin and yang of cell death control Circ Res 2012 111 1208 1221 23065344 PMC3538875
  31. Labbadia J Morimoto RI Huntington’s disease: underlying molecular mechanisms and emerging concepts Trends Biochem Sci 2013 38 378 385 23768628 PMC3955166
  32. Letko G Hofs T Liese W [Binding of glycolytic enzymes on rat liver mitochondria] Acta Biol Med Ger 1973 30 365 374 4271617
  33. Li Q Lau A Morris TJ Guo L Fordyce CB Stanley EF A syntaxin 1, Galpha(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization J Neurosci 2004 24 4070 4081 15102922 PMC6729428
  34. Li SH Li XJ Huntingtin-protein interactions and the pathogenesis of Huntington’s disease Trends Genet 2004 20 146 154 15036808
  35. Li WW Li J Bao JK Microautophagy: lesser-known self-eating Cell Mol Life Sci 2012 69 1125 1136 22080117 PMC11114512
  36. Li L Chen Y Gibson SB Starvation-induced autophagy is regulated by mitochondrial reactive oxygen species leading to AMPK activation Cell Signal 2013 25 50 65 23000343
  37. Martin DD Ladha S Ehrnhoefer DE Hayden MR Autophagy in Huntington disease and huntingtin in autophagy Trends Neurosci 2015 38 26 35 25282404
  38. Mazzola JL Sirover MA Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer’s disease and in Huntington’s disease fibroblasts J Neurochem 2001 76 442 449 11208907
  39. Mazzola JL Sirover MA Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders? Neurotoxicology 2002 23 603 609 12428732
  40. Michalik A Van Broeckhoven C Pathogenesis of polyglutamine disorders: aggregation revisited Hum Mol Genet 2003 12 R173 R186 (Spec No 2): 14504263
  41. Mizushima N Yamamoto A Hatano M Kobayashi Y Kabeya Y Suzuki K Tokuhisa T Ohsumi Y Yoshimori T Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells J Cell Biol 2001 152 657 668 11266458 PMC2195787
  42. Mochly-Rosen D Disatnik MH Qi X The challenge in translating basic research discoveries to treatment of Huntington disease Rare Dis 2014 2 e28637 25054095 PMC4091548
  43. Morero RD Vinals AL Bloj B Farias RN Fusion of phospholipid vesicles induced by muscle glyceraldehyde-3-phosphate dehydrogenase in the absence of calcium Biochemistry 1985 24 1904 1909 4016090
  44. Nixon RA The role of autophagy in neurodegenerative disease Nat Med 2013 19 983 997 23921753
  45. Novak MJ Tabrizi SJ Huntington’s disease BMJ 2010 340 c3109 20591965
  46. Okamoto K Kondo-Okamoto N Ohsumi Y Mitochondria-anchored receptor Atg32 mediates degradation of mitochondria via selective autophagy Dev Cell 2009 17 87 97 19619494
  47. Orr AL Li S Wang CE Li H Wang J Rong J Xu X Mastroberardino PG Greenamyre JT Li XJ N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking J Neurosci 2008 28 2783 2792 18337408 PMC2652473
  48. Oyama R Yamamoto H Titani K Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer’s disease brain by immunoprecipitation Biochim Biophys Acta 2000 1479 91 102 11004532
  49. Patterson RL van Rossum DB Kaplin AI Barrow RK Snyder SH Inositol 1,4,5-trisphosphate receptor/GAPDH complex augments Ca2+ release via locally derived NADH Proc Natl Acad Sci USA 2005 102 1357 1359 15677321 PMC547892
  50. Paulson HL Perez MK Trottier Y Trojanowski JQ Subramony SH Das SS Vig P Mandel JL Fischbeck KH Pittman RN Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3 Neuron 1997 19 333 344 9292723
  51. Peralta D Bronowska AK Morgan B Doka E Van Laer K Nagy P Grater F Dick TP A proton relay enhances HO sensitivity of GAPDH to facilitate metabolic adaptation Nat Chem Biol 2015 11 156 163 25580853
  52. Picard M White K Turnbull DM Mitochondrial morphology, topology, and membrane interactions in skeletal muscle: a quantitative three-dimensional electron microscopy study J Appl Physiol (1985) 2013 114 161 171 23104694 PMC3544498
  53. Puder M Soberman RJ Glutathione conjugates recognize the Rossmann fold of glyceraldehyde-3-phosphate dehydrogenase J Biol Chem 1997 272 10936 10940 9099752
  54. Reddy PH Reddy TP Manczak M Calkins MJ Shirendeb U Mao P Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases Brain Res Rev 2011 67 103 118 21145355 PMC3061980
  55. Reddy PH Shirendeb UP Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington’s disease Biochim Biophys Acta 2012 1822 101 110 22080977 PMC3249480
  56. Ross CA Tabrizi SJ Huntington’s disease: from molecular pathogenesis to clinical treatment Lancet Neurol 2011 10 83 98 21163446
  57. Schulze H Schuler A Stuber D Dobeli H Langen H Huber G Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer’s beta-amyloid precursor protein J Neurochem 1993 60 1915 1922 8473906
  58. Schweers RL Zhang J Randall MS Loyd MR Li W Dorsey FC Kundu M Opferman JT Cleveland JL Miller JL NIX is required for programmed mitochondrial clearance during reticulocyte maturation Proc Natl Acad Sci USA 2007 104 19500 19505 18048346 PMC2148318
  59. Seidler NW Basic biology of GAPDH Adv Exp Med Biol 2013 985 1 36 22851445
  60. Shirendeb U Reddy AP Manczak M Calkins MJ Mao P Tagle DA Reddy PH Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington’s disease: implications for selective neuronal damage Hum Mol Genet 2011 20 1438 1455 21257639 PMC3049363
  61. Song W Chen J Petrilli A Liot G Klinglmayr E Zhou Y Poquiz P Tjong J Pouladi MA Hayden MR Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity Nat Med 2011 17 377 382 21336284 PMC3051025
  62. Sun B Fan W Balciunas A Cooper JK Bitan G Steavenson S Denis PE Young Y Adler B Daugherty L Polyglutamine repeat length-dependent proteolysis of huntingtin Neurobiol Dis 2002 11 111 122 12460551
  63. Tal MC Sasai M Lee HK Yordy B Shadel GS Iwasaki A Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling Proc Natl Acad Sci USA 2009 106 2770 2775 19196953 PMC2650341
  64. Tarze A Deniaud A Le Bras M Maillier E Molle D Larochette N Zamzami N Jan G Kroemer G Brenner C GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization Oncogene 2007 26 2606 2620 17072346
  65. Tisdale EJ Glyceraldehyde-3-phosphate dehydrogenase is phosphorylated by protein kinase Ciota/lambda and plays a role in microtubule dynamics in the early secretory pathway J Biol Chem 2002 277 3334 3341 11724794
  66. Trettel F Rigamonti D Hilditch-Maguire P Wheeler VC Sharp AH Persichetti F Cattaneo E MacDonald ME Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells Hum Mol Genet 2000 9 2799 2809 11092756
  67. Wexler NS Lorimer J Porter J Gomez F Moskowitz C Shackell E Marder K Penchaszadeh G Roberts SA Gayan J Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington’s disease age of onset Proc Natl Acad Sci USA 2004 101 3498 3503 14993615 PMC373491
  68. Wong YC Holzbaur EL The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation J Neurosci 2014 34 1293 1305 24453320 PMC3898289
  69. Wright DJ Renoir T Smith ZM Frazier AE Francis PS Thorburn DR McGee SL Hannan AJ Gray LJ N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington’s disease Transl Psychiatry 2015 5 e492 25562842 PMC4312826
  70. Wu J Lin F Qin Z Sequestration of glyceraldehyde-3-phosphate dehydrogenase to aggregates formed by mutant huntingtin Acta Biochim Biophys Sin 2007 39 885 890 17989880
  71. Wyttenbach A Swartz J Kita H Thykjaer T Carmichael J Bradley J Brown R Maxwell M Schapira A Orntoft TF Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington’s disease Hum Mol Genet 2001 10 1829 1845 11532992
  72. Wyttenbach A Sauvageot O Carmichael J Diaz-Latoud C Arrigo AP Rubinsztein DC Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin Hum Mol Genet 2002 11 1137 1151 11978772
  73. Xiong Y Peterson PL Lee CP Effect of N-acetylcysteine on mitochondrial function following traumatic brain injury in rats J Neurotrauma 1999 16 1067 1082 10595823
  74. Yano H Baranov SV Baranova OV Kim J Pan Y Yablonska S Carlisle DL Ferrante RJ Kim AH Friedlander RM Inhibition of mitochondrial protein import by mutant huntingtin Nat Neurosci 2014 17 822 831 24836077 PMC4174557
  75. Yogalingam G Hwang S Ferreira JC Mochly-Rosen D Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) phosphorylation by protein kinase Cdelta (PKCdelta) inhibits mitochondria elimination by lysosomal-like structures following ischemia and reoxygenation-induced injury J Biol Chem 2013 288 18947 18960 23653351 PMC3696670
  76. Zheng L Roeder RG Luo Y S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component Cell 2003 114 255 266 12887926
  77. Zuccato C Valenza M Cattaneo E Molecular mechanisms and potential therapeutical targets in Huntington’s disease Physiol Rev 2010 90 905 981 20664076

Cited by

Sorted by citations

Authors
Hwang, S., Disatnik, M., & Mochly‐Rosen, D.
Affiliations
Stanford Medicine (US)
Corresponding author
Mochly‐Rosen, Daria
Venue
EMBO Molecular Medicine
Published
2015-08-12
Volume
7
Issue
10
Pages
1307-1326
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W2130120481
Cited by
153
References
8
Citations by year
2026: 6 · 2025: 8 · 2024: 19 · 2023: 19 · 2022: 11 · 2021: 26 · 2020: 15 · 2019: 9 · 2018: 13 · 2017: 12 · 2016: 15
FWCI
6.22
Type
journal article
Language
en
Open access
Locations
  • EMBO Molecular Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
University of Cambridge
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
Huntington's disease, mitophagy, glyceraldehyde-3-phosphate dehydrogenase, polyglutamine expansion, mitochondrial dysfunction, cell death, neurodegeneration
MeSH terms
Huntingtin Protein, Animals, Cell Survival, Humans, Huntington Disease, Mitochondria, Nerve Tissue Proteins, Nuclear Proteins, Polyglutamic Acid, PC12 Cells, Mice, Knockout, Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+), Mice, Rats, Mitophagy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review